PREVALENCE OF ASYMPTOMATIC HYPERURICEMIA AMONG PATIENS WITH ISCHEMIC HEART DISEASE
DOI:
https://doi.org/10.11603/1811-2471.2017.v0.i2.7727Keywords:
cardiac ischemia, asymptomatic hyperuricemia, metabolic syndrome.Abstract
We examined 206 patiens with stable angina pectoris, of wоmеn 90 (43,7%), men 116 (56.3%), had an average age of 59,5±11.1 years. According to the results of the study, asymptomatic hyperuricemia(AHU) was revealed in 44% of patiens with coronary artery disease and positive correlation was found with the metabolic syndrome (MS), which confirms the role of AHU in the development of cardiovascular risk and requires preventive correction with uricosuric drugs.
References
Bilchenko, A.V. (2009). Giperurikemiya kak faktor riska serdechno-sosudistoy zabolevayemosti i smertnosti [Hyperuricemia as a risk factor for cardiovascular morbidity and mortality]. Russkiy Meditsinskiy Zhurnal - Russian Medical Journal, 10, 46-48 [in Russian].
Mychka, V.B., Zhernakova, Yu.V., Chazova, I.E. (2010). Rekomendatsii ekspertov Vserossiyskogo obshchestva kardiologov po diagnostike i lecheniyu metabolicheskogo sindroma (vtoroy peresmotr) [Recommendations of experts of the All-Russian Society of Cardiologists on Diagnosis and Treatment of Metabolic Syndrome (second revision)]. Doktor.ru - Doktor.ru., 3, 15-18 [in Russian].
Tashkenbayeva E.N., Alyavi, A.L., Togayev, D.Kh. (2014). Bessimptomnaya giperurikemiya, patogeneticheskiye aspekty, klinika prognozirovaniye i korrektsiya [Asymptomatic hyperuricemia, pathogenetic aspects, clinic forecasting and correction]. FAN, 176 [in Russian].
Tashkenbayeva E.N. Giperurikemiya v patogeneze, klinike metabolicheskogo sindroma i razvitiye serdechno- sosudistykh oslozhneniy [Hyperuricemia in pathogenesis, the clinic of metabolic syndrome and development of cardiovascular complications]. Dissertatsiya – Thesis. 216 [in Russian].
Khodzhakuliyev, B.G., Begencheva, G.O., Akhmedova, D.M., Mukhamedov, M.B., Kulyyeva, E.S. (2014). Klinicheskoye znacheniye giperurikemii i obmena mochevoy kisloty v patologii serdechno-sosudistoy sistemy [Clinical significance of hyperuricemia and uric acid metabolism in the pathology of the cardiovascular system]. Molodoy uchenyy - Young Scientist, 18, 178-184. [in Russian].
Becker, M.A., Schumacher, H.R., Jr. Wortmann, R.L., et al. (2005). Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med, 353:2450–61.
Dalbeth, N., Merriman, T. (2009). Cristal ball gazing: new therapeutic targets for hyperuricaemia and gout. Rheumatology (Oxford), 48: 222–6, 178-184.
Choi, H.K., Curhan, G. (2007). Independent impact of gout on mortality and risk for coronary heart disease. Circulation, 116, 894–900.
Tashkenbaeva, Е.N., Togaev, D.Kh., Ziyadullaev, Sh.Kh. (2016). Study of relation of polymorphism Gene Glut9 with coronary heart disease associated asympthomatic hyperuricemia in Uzbek population. European Science Review, 9-10, 136-138.
Togaev, D.Kh., Tashkenbaeva, Е.N., Ziyadullaev, Sh.Kh, Kadirova, F.Sh. (2016). Relation of Polymorphism Gene Urat-1 with Coronary Heart Disease Associated Asymptomatic Hyperuricemia in Uzbek Population. American Journal of Medicine and Medical Sciences, 6(3), 92-94.
